p53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine

Cancer Letters

Volumn 105, Issue 1, 1996, Pages 105-112

  Masui, Tsuneo ^a   Dong, Yimin ^b   Yamamoto, Shinji ^b   Takada, Nobuyasu ^b   Nakanishi, Hayao ^a   Inada, Ken Ichi ^a   Fukushima, Shoji ^b   Tatematsu, Masae ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

H ras; N Butyl N (4 hydroxybutyl)nitrosamine; p53; Polymerase chain reaction single strand conformation polymorphism analysis; Urinary bladder

Indexed keywords

DNA; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER GENETICS; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; MALE; MUTATION RATE; NONHUMAN; ONCOGENE H RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SINGLE STRAND CONFORMATION POLYMORPHISM; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0006579901     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04268-1     Document Type: Article

References (26)

1. [1] Brugge, J., Curran, T., Harlow, E. and McCormick, F. (Editors) (1991) Origins of Human Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
2. [2] Tominaga, O., Hamelin, R., Remvikos, Y., Salmon, R.J. and Thomas, G. (1992) p53 from basic research to clinical applications. Crit. Rev. Oncogenesis, 3, 257-282.
3. [3] Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
4. [4] Vogelstein, B. and Kinzler, K.W. (1992) p53 function and dysfunction. Cell, 70, 523-526.
5. [5] Levine, A.J., Momand, J. and Finlay, C.A. (1991) The p53 tumor suppressor gene. Nature, 351, 453-456.
6. [6] Boss, J.L. (1989) ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689.
7. [7] Perucca, D., Szepetowski, P., Simon, M.-P. and Gaudray, P. (1990) Molecular genetics of human bladder carcinomas. Cancer Genet. Cytogenet., 49, 143-156.
8. [8] Nagata, Y., Abe, M., Kobayashi, K., Saiki, S., Kotake, T., Yoshikawa, K., Ueda, R., Nakayama, E. and Shiku, H. (1990) Point mutations of c-ras genes in human bladder cancer and kidney cancer. Jpn. J. Cancer Res., 81, 22-27.
9. [9] Sidransky, D., Eschenbach, A.V., Tsai, Y.C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S.R., Frost, P. and Vogelstein, B. (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252, 706-709.
10. [10] Fujimoto, K., Yamada, Y., Okajima, E., Kakizoe, T., Sasaki, H., Sugimura, T. and Terada, M. (1992) Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res., 52, 1393-1398.
11. [11] Ito, N., Hiasa, Y., Tamai, A., Okamjima, E. and Kitamura, H. (1969) Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Gann, 60, 401-410.
12. [12] Fukushima, S., Hirose, M., Tsuda, H., Shirai, T., Hirao, K., Arai, M. and Ito, N. (1976) Histological classification of urinary bladder cancers in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann, 67, 81-90.
13. [13] Masui, T., Don, I., Takad, N., Ogawa, K., Shirai, T. and Fukushima, S. (1994) p53 mutations in early neoplastic lesions of the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis, 15, 2379-2381.
14. [14] Japanese Urological Association and The Japanese Pathological Society (Editors) (1992) General Rule for Clinical and Pathological Studies on Bladder Cancer, 3rd edn. Kanehara Shuppan, Tokyo (in Japanese).
15. [15] Ohshima, M., Fukushima, S., Okamura, T., Asamoto, M., Okajima, E., Washida, H., Ueda, K., Obata, K. and Ito, N. (1995) Histopathological analysis of 98 urinary bladder carcinoma cases by the serial section whole-organ approach. J. Urol. Pathol., 3, 1-15.
16. [16] Maniatis, T., Fritsch, E.F. and Sambrook, J. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
17. [17] Hulla, J.E. and Schneider, R.P. (1993) Structure of the rat p53 tumor suppressor gene. Nucleic Acids Res., 21, 713-717.
18. [18] Orita, M., Suzuki, Y., Sekiya, T. and Hayashi, K. (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874-879.
19. [19] Makino, H., Ishizaka, Y., Tsujimoto, A., Nakamura, T., Onda, M., Sugimura, T. and Nagao, M. (1992) Rat p53 gene mutations in primary zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Proc. Natl. Acad. Sci. USA, 89, 4850-4854.
20. [20] Ruta, M., Wolford, R., Dhar, R., Defeo-Jones, D., Ellis, R.W. and Scolnick, E.M. (1986) Nucleotide sequence of the two rat cellular rasH genes. Mol. Cell. Biol., 6, 1706-1710.
21. [21] Soussi, T., Fromentel, C.C.d., Breugnot, C. and May, E. (1988) Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein. Nucleic Acids Res., 16, 11384.
22. [22] Masui, T., Mann, A.M., Macatee, T.L., Okamura, T., Garland, E.M., Smith, R.A. and Cohen, S.M. (1992) Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis, 13, 2281-2285.
23. 6-(4-hydroxybutyl)guanine in urothelial and hepatic DNA of rats given the bladder carcinogen N-nitrosobutyl(4-hydroxybutyl)amine. Carcinogenesis, 15, 2297-2301.
24. [24] Jones, R.F., Matuszyk, J., Debiec-Rychter, M. and Wang, C.Y. (1994) Mutation and altered expression of p53 genes in experimental rat bladder tumor cells. Mol. Carcinogenesis, 9, 95-104.
25. [25] Asamoto, M., Mann, A.M., Macatee, T.L. and Cohen, S.M. (1994) Mutations and expression of the p53 gene in rat bladder carcinomas and cell lines. Mol. Carcinogenesis, 9, 236-244.
26. [26] Spruck, I., C.H., Rideout, I., W.M., Olumi, A.F., Ohneseit, P.F., Yang, A.S., Tsai, Y.C., Nichols, P.W., Horn, T., Hermann, G.G., Steven, K., Ross, R.K., Yu, M.C. and Jones, P.A. (1993) A distinct pattern of p53 mutations in bladder cancer. Cancer Res., 53, 1162-1166.